Selachyl alcohol as an adjunct to radiation treatment of carcinoma of the cervix.
D001792:Blood Platelets / Q000528:radiation effects; D002277:Carcinoma / Q000401:mortality / Q000532:radiotherapy*; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D004987:Ethers / Q000009:adverse effects / Q000627:therapeutic use*; D005233:Fatty Alcohols / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D006413:Hematopoietic System / Q000187:drug effects / Q000528:radiation effects*; D006454:Hemoglobins / Q000528:radiation effects; D006801:Humans; D007962:Leukocytes / Q000528:radiation effects; D008875:Middle Aged; D010919:Placebos; D011830:Radiation Effects; D011837:Radiation-Protective Agents; D013997:Time Factors; D002583:Uterine Cervical Neoplasms / Q000401:mortality / Q000532:radiotherapy*
D004987:Ethers; D005233:Fatty Alcohols; D006454:Hemoglobins; D010919:Placebos; D011837:Radiation-Protective Agents